| scholarly article | Q13442814 |
| P2093 | author name string | Feldberg W | |
| Kellaway CH | |||
| P2860 | cites work | An apparatus for perfusing the mammalian heart | Q80323078 |
| The nature of the vaso-dilator constituents of certain tissue extracts | Q80325972 | ||
| Rhythmic responses of smooth muscle | Q80329509 | ||
| Liberation of histamine from the perfused lung by snake venoms | Q80329520 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | venom | Q3386847 |
| P304 | page(s) | 187-226 | |
| P577 | publication date | 1938-11-01 | |
| P1433 | published in | Journal of Physiology | Q7743612 |
| P1476 | title | Liberation of histamine and formation of lysocithin-like substances by cobra venom | |
| P478 | volume | 94 |
| Q71510993 | 11-Trans leukotriene C: a naturally occurring slow reacting substance |
| Q40096947 | A Short History of the Mast Cell |
| Q37665290 | Advances in mast cell biology: new understanding of heterogeneity and function |
| Q51043743 | Allergy and ACTH. |
| Q70087520 | Anti-asthmatic effects of immunization with cobra venom |
| Q72574082 | Anti-asthmatic properties of anti-snake-venom serum |
| Q36269088 | Antigen-induced release of slow reacting substance of anaphylaxis (SRS-A rat) in rats prepared with homologous antibody |
| Q79459238 | Antihistamine substances |
| Q37113051 | Aspects of release of pharmacologically active substances from the lungs by chemical stimuli |
| Q33930453 | Asthma--the changing face of drug therapy |
| Q77750849 | Binding of YM158, a new dual antagonist for leukotriene D4 and thromboxane A2 receptors, to guinea pig lung membranes |
| Q70215480 | Binding sites for 3H-LTC4 in membranes from guinea pig ileal longitudinal muscle |
| Q41473587 | Biological activities of a chemically synthesized form of leukotriene E4 |
| Q72429396 | Biomolecular structure determination by mass spectrometry |
| Q53921665 | Characteristics of the uptake of cysteine-containing leukotrienes by isolated hepatocytes |
| Q39907131 | Chemical mediators of the vascular phenomena of the acute inflammatory reaction and of immediate hypersensitivity |
| Q40088804 | Chemical studies on slow reacting substances/leukotrienes |
| Q72462116 | Conversion of 14C-labeled eicosapentaenoic acid (n-3) to leukotriene C5 |
| Q39879007 | Current concepts of the pathogenesis and management of asthma |
| Q72886780 | Detection of leukotriene A4 as an intermediate in the biosynthesis of leukotrienes C4 and D4 |
| Q34483306 | Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma. |
| Q51047232 | Distribution of histamine and substance P in the wall of the dog's digestive tract. |
| Q35566594 | Drugs for asthma |
| Q36344130 | Dynamics of leukotriene C production by macrophages |
| Q78385306 | ENZYMATIC PROCESSES IN THE PATHOGENESIS OF ALLERGIC REACTIONS |
| Q58979312 | Efflux of Prostaglandin from Adrenal Glands Stimulated with Acetylcholine |
| Q46274137 | Efflux of slow reacting substance (SRS) and prostaglandins from cat paws perfused with d-tubocurarine and n-octylamine |
| Q39698325 | Eicosanoids, plasma membranes, and molecular mechanisms of spinal cord injury |
| Q42951993 | Enzyme inhibitions by snake venoms |
| Q72710896 | Experimental studies on the problem of mast cell degranulation caused by snake venom |
| Q93632361 | Experimental studies on the spitting cobra ophthalmia (Naja nigricollis) |
| Q72914887 | Formation of Leukotrienes E3, E4,E5 in Rat Basophilic Leukemia Cells |
| Q33836674 | From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist |
| Q34255111 | From studies of biochemical mechanism to novel biological mediators: Prostaglandin endoperoxides, thromboxanes, and leukotriences |
| Q42963956 | Haemolysins in venoms of Australian snakes. Observations on the haemolysins of the venoms of some Australian snakes and the separation of phospholipase A from the venom of Pseudechis porphyriacus |
| Q82312253 | Histamine |
| Q58937779 | Histamine of the Reptilian Stomach and Lung |
| Q34794348 | Histamine release by bee venom phospholipase a and mellitin in the rat |
| Q72644278 | Histamine release from fawn-hooded rat mast cells is not potentiated by phosphatidylserine |
| Q80330047 | Histamine release in anaphylactic shock from various tissues of the guinea-pig |
| Q39334733 | Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom |
| Q36408961 | Identification of the slow reacting substances from cat paws |
| Q48202727 | Isolated tissue and binding studies of YM-17690, a novel and non-analogous leukotriene agonist |
| Q46100252 | Isolation and characterization of a noncytotoxic mast-cell activator from cobra venom |
| Q72534068 | Kinetics of the conversion of leukotriene C by γ-glutamyl transpeptidase |
| Q28345833 | Leukotriene C(4) enhances the contraction of porcine tracheal smooth muscle through the activation of Y-27632, a rho kinase inhibitor, sensitive pathway |
| Q44009902 | Leukotriene C4 inhibits ATP-dependent transport of glutathione S-conjugate across rat heart sarcolemma. Implication for leukotriene C4 translocation mediated by glutathione S-conjugate carrier |
| Q33972104 | Leukotriene C: a slow-reacting substance from murine mastocytoma cells |
| Q36363644 | Leukotriene D: a slow reacting substance from rat basophilic leukemia cells |
| Q41582379 | Leukotriene activity modulation in asthma |
| Q40841076 | Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions |
| Q36882130 | Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents |
| Q36342592 | Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. |
| Q55686747 | Leukotriene receptor antagonists: clinical effects. |
| Q37145833 | Leukotriene signaling in atherosclerosis and ischemia |
| Q40842366 | Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma |
| Q57638537 | Leukotrienes and Prostaglandins in Asthma |
| Q93668774 | Leukotrienes and immediate hypersensitivity |
| Q40087798 | Leukotrienes and lung disease |
| Q53960231 | Leukotrienes and slow reacting substance of anaphylaxis (SRS-A). |
| Q40387180 | Leukotrienes as a target in asthma therapy |
| Q49314573 | Leukotrienes in disease. Implications for drug development |
| Q40133100 | Leukotrienes, allergy and inflammation |
| Q34254403 | Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation |
| Q40141738 | Leukotrienes: clinical significance |
| Q39521976 | Leukotrienes: regulation of biosynthesis, metabolism, and bioactivity |
| Q37061552 | Leukotrienes: their possible role in pulpal and periapical diseases |
| Q40955961 | Management of asthma with zafirlukast. Clinical experience and tolerability profile |
| Q34744323 | Maurício Rocha e Silva MD: snake venom, bradykinin and the rise of autopharmacology |
| Q28181156 | Mechanism of chronic urticaria exacerbation by aspirin |
| Q46952942 | Mechanism of leukotriene-induced contraction of isolated guinea pig tracheal smooth muscle |
| Q46900873 | Metabolism of Arachidonic Acid by Isolated Lung Cells and Transcellular Biosynthesis of Thromboxanes |
| Q46218967 | Metabolism of leukotriene C3 in the guinea pig. Identification of metabolites formed by lung, liver, and kidney |
| Q36403505 | Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus |
| Q33729339 | New perspectives for asthma treatment: anti-leukotriene drugs |
| Q42366094 | Observations on a substance in human plasma which gives a slow contraction of guinea-pig gut in vitro |
| Q71501642 | Observations on the effects of the bite of a venomous snake on children and adults |
| Q42631715 | On the preparation of highly purified slow reacting substance of anaphylaxis (SRS-A) from biological extracts |
| Q34175861 | Our perception of the mast cell from Paul Ehrlich to now. |
| Q79068480 | Pathology of sea-snake poisoning |
| Q78784435 | Pharmacological characteristics of bradykinin B |
| Q27863451 | Pharmacological inhibition of leukotriene actions |
| Q38160695 | Pharmacological studies of pulmonary anaphylaxis in vitro: a review |
| Q70575029 | Platelet-activating factor (PAF-acether) |
| Q35109122 | Pranlukast: a review of its use in the management of asthma |
| Q34192889 | Prostaglandins, thromboxanes and leukotrienes in clinical medicine |
| Q39289170 | Purification and Some Physicochemical Properties of Slow-Reacting Substance of Anaphylaxis (SRS-A) from Sensitized Guinea Pig Lung |
| Q70996332 | Rapid invivo metabolism of Leukotriene C3 in the monkey, Macacairus |
| Q59053300 | Release of 5-Hydroxytryptamine from Rat Mast Cells in vitro |
| Q52470242 | Release of histamine and formation of smooth-muscle stimulating principles in guinea-pig lung tissue induced by antigen and bee venom phosphatidase A. |
| Q71628611 | Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay |
| Q46231942 | Release of slow reacting substance from the guinea-pig lung by phospholipases A2 of Vipera russelli snake venom |
| Q89548477 | Review of montelukast use over the past 20 years and monitoring of its effects |
| Q37982662 | Role of basic science in the development of new medicines: examples from the eicosanoid field |
| Q33988564 | Role of leukotrienes in asthma pathophysiology |
| Q39847943 | SNAKE VENOM OPHTHALMIA. |
| Q36307397 | Slow reacting substances (leukotrienes): enzymes involved in their biosynthesis |
| Q42241095 | Slow-Reacting Substances and Their Structural Elucidation |
| Q36801782 | Slow-reacting substance of anaphylaxis |
| Q42241286 | Slow-reacting substances and their formation by a lipoxygenase pathway |
| Q42952277 | Some observations on reversed anaphylaxis |
| Q72421017 | Stereochemistry of leukotriene C-1 |
| Q39296258 | Structure of leukotriene C identification of the amino acid part |
| Q45719314 | Studies on filamentary forms of influenza virus with special reference to the use of dark-ground-microscopy. |
| Q40315563 | Studies on the pectinolytic anaerobes Clostridium flavum and Clostridium laniganii |
| Q44009936 | Studies on the pre- and posthepatic plasma histamine concentrations and their possible pathophysiological effects in liver cirrhosis (author's transl) |
| Q42335943 | The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions |
| Q42207107 | The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo |
| Q40042453 | The Immune Reaction in Pulmonary Disease |
| Q80330354 | The action of bee venom, cobra venom and lysolecithin on the adrenal medulla |
| Q33836669 | The discovery of the leukotrienes |
| Q39221903 | The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses |
| Q38333858 | The emergence of potent and selective peptide leukotriene receptor antagonists |
| Q34568162 | The formation of lysocithin and of a muscle-stimulating substance by snake venoms |
| Q73536403 | The histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species |
| Q72699197 | The histamine content and histidine decarboxylase activity of some marine and terrestrial animals from the West Indies |
| Q34367655 | The history of mast cell and basophil research - some lessons learnt from the last century |
| Q28145246 | The leukotriene C(4) synthase gene and asthma |
| Q46951082 | The mast cells in experimental dinitrochlorobenzene eczema in the guinea pig: their reaction after administration of compound 48/80 |
| Q52551889 | The mechanism of the disruption of mast cells produced by compound 48/80. |
| Q39873981 | The pharmacology of slow reacting substance C and of arachidonic acid |
| Q48910462 | The pharmacology of slow reacting substance C and of arachidonic acid. 1973. |
| Q39731895 | The role of arachidonic acid metabolites in mononuclear phagocytic cell interactions |
| Q41820875 | The separation and properties of the neurotoxins from the venom of the tiger snake Notechis scutatus scutatus |
| Q78755751 | The theoretical principles of allergy |
| Q37682077 | Transmembrane signaling, then and now: the decade of the eighties |
| Q34196648 | Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma |
| Q77421066 | [Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class] |
Search more.